TELA Bio, Inc. - 8-K Filing

TELA Bio announces CFO departure and $17M annual cost reduction plan with a one-time $1.5M restructuring charge (Items: 2.05 Costs Associated with Exit or Disposal Activities, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $TELA

Read the full article at SEC EDGAR

More Regulatory news